Risk of malignancy in sonographically confirmed septated cystic ovarian tumors (Q43950332)

28 November 2017

Risk of malignancy in sonographically confirmed septated cystic ovarian tumors (English)

1 reference

28 November 2017

7

Leigh Seamon

1 reference

28 November 2017

Brook A Saunders

1

1 reference

28 November 2017

Iwona Podzielinski

2

1 reference

28 November 2017

Rachel A Ware

3

1 reference

28 November 2017

Scott Goodrich

4

1 reference

28 November 2017

Christopher P DeSimone

5

1 reference

28 November 2017

Fred R Ueland

6

1 reference

28 November 2017

Jessalyn Ubellacker

8

1 reference

28 November 2017

Edward J Pavlik

9

1 reference

28 November 2017

Richard J Kryscio

10

1 reference

28 November 2017

John R van Nagell

11

1 reference

28 November 2017

language of work or name

English

0 references

publication date

15 June 2010

1 reference

28 November 2017

1 reference

28 November 2017

118

1 reference

28 November 2017

3

1 reference

28 November 2017

278-282

1 reference

28 November 2017

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.013

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.013

Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.013

Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.013

Results from four rounds of ovarian cancer screening in a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.013

The malignant potential of small cystic ovarian tumors in women over 50 years of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.013

Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.013

Ovarian volume related to age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.013

Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.013

The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.013

Phase 2 trial of single-agent gemcitabine in platinum-paclitaxel refractory ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.013

Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.013

Predicting risk of malignancy in adnexal masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.013

10.1016/J.YGYNO.2010.05.013

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference